Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +102.7% | +35.7% | 2 / 3 | +28.0% | +15.34 pp | +29.23 pp | +5.6% | 2.60 | 8.48 | 226 | +28,0% | 1,3 | +102,6% | 8.48 | 292.39 | −97,1% |
| Pts | 12 | 8 | 8 | 12 | 12 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 5.350 (close price on 2026-10-19)EPS (TTM): 631,1
Financial charts
1.Revenue & growth
VND bn226Q2/26
1.Revenue & growth
VND bn226Q2/26
2.Profit & growth
VND bn1,34Q2/26
3.Profit mix (Penman)
VND bn101Q2/26
4.Margins & cost structure
%37.3%Q2/26
5.Returns & cash cycle
% · days2.8%Q2/26
6.Earnings quality & cash
VND bn34,8Q2/26
7.Asset structure
VND bn4.454Q2/26
8.Funding & debt health
VND bn · times4.454Q2/26
9.Revenue backlog
VND bn114Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %14Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-2.2%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26